- Home
- LGCB vs ATHA Comparison
LGCB vs ATHA Comparison
Compare LGCB & ATHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGCB
- ATHA
- Stock Information
- Founded
- LGCB 2011
- ATHA 2011
- Country
- LGCB Japan
- ATHA United States
- Employees
- LGCB N/A
- ATHA N/A
- Industry
- LGCB
- ATHA Medicinal Chemicals and Botanical Products
- Sector
- LGCB
- ATHA Health Care
- Exchange
- LGCB Nasdaq
- ATHA Nasdaq
- Market Cap
- LGCB 19.7M
- ATHA 16.1M
- IPO Year
- LGCB 2023
- ATHA 2020
- Fundamental
- Price
- LGCB $1.96
- ATHA $4.70
- Analyst Decision
- LGCB
- ATHA
- Analyst Count
- LGCB 0
- ATHA 0
- Target Price
- LGCB N/A
- ATHA N/A
- AVG Volume (30 Days)
- LGCB 292.1K
- ATHA 27.5K
- Earning Date
- LGCB 07-03-2025
- ATHA 11-06-2025
- Dividend Yield
- LGCB N/A
- ATHA N/A
- EPS Growth
- LGCB N/A
- ATHA N/A
- EPS
- LGCB N/A
- ATHA N/A
- Revenue
- LGCB $8,993,265.00
- ATHA N/A
- Revenue This Year
- LGCB N/A
- ATHA N/A
- Revenue Next Year
- LGCB N/A
- ATHA N/A
- P/E Ratio
- LGCB N/A
- ATHA N/A
- Revenue Growth
- LGCB 5.80
- ATHA N/A
- 52 Week Low
- LGCB $1.22
- ATHA $2.20
- 52 Week High
- LGCB $6.83
- ATHA $7.47
- Technical
- Relative Strength Index (RSI)
- LGCB 54.90
- ATHA 61.92
- Support Level
- LGCB $1.47
- ATHA $4.44
- Resistance Level
- LGCB $2.25
- ATHA $4.89
- Average True Range (ATR)
- LGCB 0.14
- ATHA 0.28
- MACD
- LGCB 0.06
- ATHA 0.00
- Stochastic Oscillator
- LGCB 68.15
- ATHA 67.23
About LGCB Linkage Global Inc
Linkage Global Inc is a cross-border e-commerce integrated service provider. It provides international e-commerce merchants, overseas brands, import and export trading enterprises, etc. with a globally selected supply chain, digital marketing, e-commerce training, international store, ERP and e-commerce software, social e-commerce and other e-commerce integrated services. The Company has two operating segments: Extend from Japan, and Other Subsidiaries from Hong Kong. The company is Committed to building a one-stop cross-border integrated service platform to make cross-border trade easier. Company operates in Japan, Hong Kong and China, with maximum revenue from Japan.
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.